期刊
JOURNAL OF PHARMACOLOGICAL SCIENCES
卷 106, 期 2, 页码 174-179出版社
JAPANESE PHARMACOLOGICAL SOC
DOI: 10.1254/jphs.FM0070087
关键词
keratinocyte; nicotinic acetylcholine receptor; SLURP-1; SLURP-2; nitrosoamine; non-neuronal cholinergic system
资金
- NCI NIH HHS [CA117327] Funding Source: Medline
- NIDCR NIH HHS [DE14173] Funding Source: Medline
- NIEHS NIH HHS [ES014384] Funding Source: Medline
Mucocutaneous keratinocytes and bronchial epithelial cells express nicotinic acetylcholine receptors (nAChRs). Emerging evidence indicates that nAChRs can be stimulated also by the tobacco-derived nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and N'-nitrosonornicotine (NNN) that can induce tumors in laboratory animals. Nitrosamines may disturb the delicate balance between cell proliferation, growth arrest, and apoptosis. A novel paradigm of cell regulation via nAChR has been discovered in studies of SLURP (secreted mammalian Ly-6/urokinase plasminogen activator receptor-related protein)-1 and -2. Experimental results suggest that SLURP-1 and -2 regulate keratinocyte proliferation, apoptosis, and differentiation. Most importantly, SLURPs and professional nicotinic antagonists can abolish, in part, the abilities of NNK and NNN to cause tumorigenic transformation of immortalized keratinocytes. Learning the pharmacology of the nitrosamine vs. SLURP action on epithelial cells may help develop an effective anti-cancer treatment and prevention programs wherein hazardous effects of tobacco products are anticipated, or even abolished, by a pharmacologic ligand of the specific nicotinic receptor acting as an antidote.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据